Selective JAK1 inhibitors and the therapeutic applications thereof: a patent review (2016-2023)
{{output}}
Introduction: The family of Janus kinases (JAKs) consists of four intracellular non-receptor tyrosine kinases: JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2). Among these four subtypes, JAK1 is the only isoform that can form hete... ...
